- Home
- PPCB vs NXGL Comparison
PPCB vs NXGL Comparison
Compare PPCB & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPCB
- NXGL
- Stock Information
- Founded
- PPCB 2007
- NXGL 1997
- Country
- PPCB Australia
- NXGL United States
- Employees
- PPCB N/A
- NXGL N/A
- Industry
- PPCB
- NXGL Medical/Dental Instruments
- Sector
- PPCB
- NXGL Health Care
- Exchange
- PPCB Nasdaq
- NXGL Nasdaq
- Market Cap
- PPCB 20.4M
- NXGL 18.7M
- IPO Year
- PPCB N/A
- NXGL 2021
- Fundamental
- Price
- PPCB $1.26
- NXGL $2.43
- Analyst Decision
- PPCB
- NXGL
- Analyst Count
- PPCB 0
- NXGL 0
- Target Price
- PPCB N/A
- NXGL N/A
- AVG Volume (30 Days)
- PPCB 337.6K
- NXGL 65.4K
- Earning Date
- PPCB 09-30-2025
- NXGL 11-10-2025
- Dividend Yield
- PPCB N/A
- NXGL N/A
- EPS Growth
- PPCB N/A
- NXGL N/A
- EPS
- PPCB N/A
- NXGL N/A
- Revenue
- PPCB N/A
- NXGL $11,672,000.00
- Revenue This Year
- PPCB N/A
- NXGL $46.60
- Revenue Next Year
- PPCB N/A
- NXGL $47.96
- P/E Ratio
- PPCB N/A
- NXGL N/A
- Revenue Growth
- PPCB N/A
- NXGL 133.02
- 52 Week Low
- PPCB $1.25
- NXGL $2.10
- 52 Week High
- PPCB $145.46
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- PPCB N/A
- NXGL 44.97
- Support Level
- PPCB N/A
- NXGL $2.38
- Resistance Level
- PPCB N/A
- NXGL $2.64
- Average True Range (ATR)
- PPCB 0.00
- NXGL 0.16
- MACD
- PPCB 0.00
- NXGL -0.02
- Stochastic Oscillator
- PPCB 0.00
- NXGL 24.53
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.